Genetic polymorphisms of UGT1A7 and cancer risk: Evidence from 21 case control studies

Cancer Investigation

Volumn 29, Issue 10, 2011, Pages 645-654

  Lu, Pei Hua ^a   Chen, Min Bin ^b   Wu, Xiao Yang ^b   Gu, Jin Hua ^b   Liu, Yuan ^c   Gu, Rong Min ^d  

^a NANJING MEDICAL UNIVERSITY   (China)

^b JIANGSU UNIVERSITY   (China)

^c First Affiliated Hospital of Nanjing Medical University   (China)

^d JIANGSU CANCER HOSPITAL   (China)

Author keywords

Cancer; Meta analysis; Polymorphism; Susceptibility; UDP glucuronosyltransferase

Indexed keywords

GLUCURONOSYLTRANSFERASE 1A7;

ALLELE; ARTICLE; ASIAN; CANCER RISK; CANCER SUSCEPTIBILITY; COLORECTAL CANCER; DISEASE ASSOCIATION; DNA POLYMORPHISM; ETHNIC DIFFERENCE; GENOTYPE; HUMAN; LIVER CELL CARCINOMA; META ANALYSIS (TOPIC); PRIORITY JOURNAL; SYSTEMATIC REVIEW;

CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUCURONOSYLTRANSFERASE; HUMANS; NEOPLASMS; POLYMORPHISM, GENETIC; PUBLICATION BIAS; RISK;

EID: 81255203810     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357907.2011.626477     Document Type: Article

References (37)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.
2. Jancova P, Anzenbacher P, Anzenbacherova E. Phase II drug metabolizing enzymes. Biomed PapMed Fac Univ Palacky Olomouc Czech Repub 2010;154:103-116.
3. Swinney R, Hsu S, Tomlinson G. Phase I and Phase II enzyme polymorphisms and childhood cancer. J Investig Med 2006;54:303-320. (Pubitemid 44955912)
4. Zheng Z, Fang JL, Lazarus P. Glucuronidation: an important mechanism for detoxification of benzo[a]pyrene metabolites in aerodigestive tract tissues. Drug Metab Dispos 2002;30:397-403. (Pubitemid 34263824)
5. Tukey RH, Strassburg CP. Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu Rev Pharmacol Toxicol 2000;40:581-616.
6. Huang MJ, Yang SS, Lin MS, Huang CS. Polymorphisms of uridine-diphosphoglucuronosyltransferase 1A7 gene in Taiwan Chinese. World J Gastroenterol 2005;11:797-802.
7. Guillemette C. Pharmacogenomics of human UDP-glucuronosyltransferase enzymes. Pharmacogenomics J 2003;3:136-158. (Pubitemid 36850156)
8. Strassburg CP, Nguyen N, Manns MP, Tukey RH. Polymorphic expression of the UDP-glucuronosyltransferase UGT1A gene locus in human gastric epithelium. Mol Pharmacol 1998;54:647-654. (Pubitemid 28480967)
9. Strassburg CP, Manns MP, Tukey RH. Expression of the UDP- glucuronosyltransferase 1A locus in human colon. Identification and characterization of the novel extrahepatic UGT1A8. J Biol Chem 1998;273:8719-8726. (Pubitemid 28176150)
10. Verlaan M, Drenth JP, Truninger K, Koudova M, Schulz HU, Bargetzi M, Kunzli B, Friess H, Cerny M, Kage A, Landt O, te Morsche RH, Rosendahl J, Luck W, Nickel R, Halangk J, Becker M, Macek M Jr, Jansen JB, Witt H. Polymorphisms of UDP-glucuronosyltransferase 1A7 are not involved in pancreatic diseases. J Med Genet 2005;42:e62.
11. Guillemette C, Ritter JK, Auyeung DJ, Kessler FK, Housman DE. Structural heterogeneity at theUDP-glucuronosyltransferase 1 locus: functional consequences of three novel missense mutations in the human UGT1A7 gene. Pharmacogenetics 2000;10:629-644.
12. Zheng Z, Park JY, Guillemette C, Schantz SP, Lazarus P. Tobacco carcinogen-detoxifying enzyme UGT1A7 and its association with orolaryngeal cancer risk. J Natl Cancer Inst 2001;93:1411-1418. (Pubitemid 32936819)
13. Araki J, Kobayashi Y, Iwasa M, Urawa N, Gabazza EC, Taguchi O, Kaito M, Adachi Y. Polymorphism of UDP-glucuronosyltransferase 1A7 gene: a possible new risk factor for lung cancer. Eur J Cancer 2005;41:2360-2365. (Pubitemid 41415614)
14. Chen K, Jin M, Zhu Y, Jiang Q, Yu W, Ma X, Yao K. Genetic polymorphisms of the uridine diphosphate glucuronosyltransferase 1A7 and colorectal cancer risk in relation to cigarette smoking and alcohol drinking in a Chinese population. J GastroenterolHepatol 2006;21:1036-1041. (Pubitemid 43823291)
15. Kong SY, Ki CS, Yoo BC, Kim JW. UGT1A7 haplotype is associated with an increased risk of hepatocellular carcinoma in hepatitis B carriers. Cancer Sci 2008;99:340-344. (Pubitemid 351228489)
16. Borentain P, Gerolami V, Ananian P, Garcia S, Noundou A, Botta-Fridlund D, Le Treut YP, Berge-Lefranc JL, Gerolami R. DNA-repair and carcinogen-metabolising enzymes genetic polymorphisms as an independent risk factor for hepatocellular carcinoma in Caucasian liver-transplanted patients. Eur J Cancer 2007;43:2479-2486. (Pubitemid 350086929)
17. Stücker I, Loriot MA, N'Koutchou G, Cenee S, Bodin L, Mulot C, Gelu-Simeon M, Pelletier L, Bronowicki JP, Degos F, Beaune P, Laurent-Puig P, Hémon D, Trinchet JC, Pelletier G. UDP-glucuronosyltransferase UGT1A7 genetic polymorphisms in hepatocellular carcinoma: a differential impact according to seropositivity of HBV or HCV markers? BMC Cancer 2007; 7:214.
18. Piepoli A, Gentile A, Valvano MR, Barana D, Oliani C, Cotugno R, Quitadamo M, Andriulli A, Perri F. Lack of association between UGT1A7, UGT1A9, ARP, SPINK1 and CFTR gene polymorphisms and pancreatic cancer in Italian patients.World J Gastroenterol 2006;12:6343-6348. (Pubitemid 44712417)
19. Kavvoura FK, Ioannidis JP.Methods formeta-analysis in genetic association studies: a review of their potential and pitfalls. Hum Genet 2008;123:1-14.
20. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315:629-634. (Pubitemid 27387172)
21. Taylor SJ, Tweedie R. Practical estimates of the effect of publication bias in meta-analysis. Australas Epidemiol 1998;5:14-17.
22. Fujita K, Ando Y, Nagashima F, Yamamoto W, Eodo H, Araki K, Kodama K, Miya T, Narabayashi M, Sasaki Y. Genetic linkage of UGT1A7 and UGT1A9 polymorphisms to UGT1A1?6 is associated with reduced activity for SN-38 in Japanese patients with cancer. Cancer Chemother Pharmacol 2007;60:515-522. (Pubitemid 47084262)
23. Fujita K, Ando Y, Nagashima F, YamamotoW, Endo H, Kodama K, Araki K, Miya T, Narabayashi M, Sasaki Y. Novel single nucleotide polymorphism of UGT1A7 gene in Japanese.DrugMetab Pharmacokinet 2006;21:75-78.
24. Lacko M, Oude Ophuis MB, Peters WH, Manni JJ. Genetic polymorphisms of smoking-related carcinogen detoxifying enzymes and head and neck cancer susceptibility. Anticancer Res 2009;29:753-761.
25. Sharma R, Ahuja M, Panda NK, Khullar M. Polymorphisms in CYP2A13 and UGT1A7 genes and head and neck cancer susceptibility in North Indians. Oral Dis 2010;16:760-768.
26. Liu J, Yang XM, Liu G, Chang LS, Zhang LR, Song DK. Association between genetic polymorphism of UGT1A7 and susceptibility of bladder cancer [in Chinese]. Zhonghua Yi Xue Za Zhi 2009;89:3122-3125.
27. Lacko M, Roelofs HM, te Morsche RH, Voogd AC, Ophuis MB, Peters WH, Manni JJ. Genetic polymorphisms in the tobacco smoke carcinogens detoxifying enzyme UGT1A7 and the risk of head and neck cancer. Head Neck 2009;31:1274-1281.
28. Feng FY, Liang G, Lu WF, Miao XP, Yu CY, Tan W, Zhou YF, Sun T, Kang B, Zhou T, Pan KF, Zhang L, Lin DX. Correlation of polymorphisms of UDP-glucuronosyltransferase 1A7 gene to genetic susceptibility of lung cancer [in Chinese]. Ai Zheng 2005;24:1085-1090.
29. Tseng CS, Tang KS, Lo HW, Ker CG, Teng HC, Huang CS. UDP- glucuronosyltransferase 1A7 genetic polymorphisms are associated with hepatocellular carcinoma risk and onset age. Am J Gastroenterol 2005;100:1758-1763.
30. Tang KS, Chiu HF, Chen HH, Eng HL, Tsai CJ, Teng HC, Huang CS. Link between colorectal cancer and polymorphisms in the uridine- diphosphoglucuronosyltransferase 1A7 and 1A1 genes. World J Gastroenterol 2005;11:3250-3254.
31. Butler LM, Duguay Y, Millikan RC, Sinha R, Gagne JF, Sandler RS, Guillemette C. Joint effects between UDP-glucuronosyltransferase 1A7 genotype and dietary carcinogen exposure on risk of colon cancer. Cancer Epidemiol Biomarkers Prev 2005;14:1626-1632. (Pubitemid 40995071)
32. van der Logt EM, Bergevoet SM, Roelofs HM, van Hooijdonk Z, te Morsche RH, Wobbes T, de Kok JB, Nagengast FM, Peters WH. Genetic polymorphisms in UDP-glucuronosyltransferases and glutathione S-transferases and colorectal cancer risk. Carcinogenesis 2004;25:2407-2415. (Pubitemid 39625181)
33. Wang Y, Kato N, Hoshida Y, Otsuka M, Taniguchi H, Moriyama M, Shiina S, Kawabe T, Ito YM, Omata M. UDP-glucuronosyltransferase 1A7 genetic polymorphisms are associated with hepatocellular carcinoma in Japanese patients with hepatitis C virus infection. Clin Cancer Res 2004;10:2441-2446. (Pubitemid 38445704)
34. Ockenga J, Vogel A, Teich N, Keim V, Manns MP, Strassburg CP. UDP glucuronosyltransferase (UGT1A7) gene polymorphisms increase the risk of chronic pancreatitis and pancreatic cancer. Gastroenterology 2003;124:1802-1808. (Pubitemid 36666777)
35. Vogel A, Ockenga J, Ehmer U, Barut A, Kramer FJ, Tukey RH, Manns MP, Strassburg CP. Polymorphisms of the carcinogen detoxifying UDP- glucuronosyltransferase UGT1A7 in proximal digestive tract cancer. Z Gastroenterol 2002;40:497-502. (Pubitemid 34856989)
36. Strassburg CP, Vogel A, Kneip S, Tukey RH, Manns MP. Polymorphisms of the human UDP-glucuronosyltransferase (UGT) 1A7 gene in colorectal cancer. Gut 2002;50:851-856. (Pubitemid 34539049)
37. Vogel A, Kneip S, Barut A, Ehmer U, Tukey RH, Manns MP, Strassburg CP. Genetic link of hepatocellular carcinoma with polymorphisms of the UDP-glucuronosyltransferase UGT1A7 gene. Gastroenterology 2001;121:1136-1144. (Pubitemid 33022094)